Find a Cancer Provider

Are you a referring physician?
I am searching for a
Reset Form
Justine V. Cohen, DO

Justine V. Cohen, DO Physician

Clinical Associate of Medicine Clinical Assistant Professor of Medicine

Dr. Cohen is employed by Penn Medicine.

Clinical Specialties


  • Hematology
  • Medical Oncology

Programs & Centers:

Board Certification:

  • Internal Medicine, 2013
  • Medical Oncology, 2017

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Philadelphia College of Osteopathic Medicine
Residency: Pennsylvania Hospital
Fellowship: Yale-New Haven Hospital


American Association for Cancer Research, National American Society of Clinical Oncology, National Impact Melanoma, National

Hospital Affiliation

Dr. Cohen is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.


Selected Publications:

Cohen JV, Sullivan RJ.: Developments in the Space of New MAPK Pathway Inhibitors for BRAF-Mutant Melanoma. Clin Cancer Res. : 2019.

Cohen JV, Flaherty KT.: Response to Immune Checkpoint Antibodies: Not All Responses Are Created Equal. Clin Cancer Res 25 (3): 910-911,2019.

Dubey D. David WS, Reynolds KL, Chute DF, Clement NF, Cohen JV, Lawrence DP, Mooradian MJ, Sullivan RJ, Guidon AC.: Immune checkpoint inhibitor related neurologic adverse events: clinical spectrum, management and outcomes. American Academy of Neurology 71st Annual Meeting, Philadelphia, PA : 2019.

Awadalla M, Mahmood SS, Groarke JD, Reynolds KL, Alvi RM, Liu SL, Hassan MZO, Rokicki A, Mercaldo N, Murphy SPT, Jones-O’Connor M, Cohen JV, Nohria A, Heinzerling LM, Kirchberger MC, Armanious M, Sullivan RJ, Chen CL, Gupta D, Shah SP, Ganatra S, Rizvi MA, Thavendiranathan P, Sahni G, Lyon AR, Tocchetti CG, Hung J, Picard MH, Lawrence DP, Thuny F, Ederhy S, Fradley MG, Neilan TG.: Decreased Global Longitudinal Strain with Myocarditis from Immune Checkpoint Inhibitors and Occurrence of Major Adverse Cardiac Events. Abramson Cancer Center Symposium, Philadelphia, PA : 2019.

Venur VA, Cohen JV, Brastianos PK.: Targeting Molecular Pathways in Intracranial Metastatic Disease. Front Oncol. 9 : 99,2019.

Cohen JV.: From Puppy to Patient: Translational Oncology. JAMA Intern Med 179 (1): 7-8,2019.

Mooradian MJ, Nasrallah M, Gainor JF, Reynolds KL, Cohen JV, Lawrence DP, Miloslavsky EM, Kohler MJ, Sullivan RJ, Schoenfeld SR.: Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experience. Semin Arthritis Rheum 48 (6): 1127-1132,2019.

Awadalla M, Golden DLA, Mahmood SS, Alvi RM, Mercaldo MD, Hassan MZO, Banerji D, Rokicki A, Mulligan C, Murphy SPT, Jones-O'Connor M, Cohen JV, Heinzerling LM, Armanious M, Sullivan RJ, Damrongwatanasuk R, Chen CL, Gupta D, Kirchberger MC, Moslehi JJ, Shah SP, Ganatra S, Thavendiranathan P, Rizvi MA, Sahni G, Lyon AR, Tocchetti CG, Mercurio V, Thuny F, Ederhy S, Mahmoudi M, Lawrence DP, Groarke JD, Nohria A, Fradley MG, Reynolds KL, Neilan TG.: Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors. J Immunother Cancer. 7 (1): 53,2019.

Bello E, Cohen JV, Mino-Kenudson M, Dougan M.: Antitumor response to microscopic melanoma in the gastric mucosa mimicking ipilimumab-induced gastritis. J Immunother Cancer. 7 (1): 41,2019.

Wang DY, Salem JE, Cohen JV, Chandra S, Menzer C, Ye F, Zhao S, Das S, Beckermann KE, Ha L, Rathmell WK, Ancell KK, Balko JM, Bowman C, Davis EJ, Chism DD, Horn L, Long GV, Carlino MS, Lebrun-Vignes B, Eroglu Z, Hassel JC, Menzies AM, Sosman JA, Sullivan RJ, Moslehi JJ, Johnson DB.: Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis. JAMA Oncol. 4 (12): 1721-1728,2018.

Chen ST, Lo J, Durbin S, Cohen JV, Reynold KL.: The role of dermatology consultation in the management of dermatologic immune-related adverse effects (irAE) among hospitalized patients. Society for Dermatology Hospitalists, San Diego, CA. : 2018.

Mahmood SS, Fradley MG, Cohen JV, Nohria A, Reynolds KL, Heinzerling LM, Sullivan RJ, Damrongwatanasuk R, Chen CL, Gupta D, Kirchberger MC, Awadalla M, Hassan MZO, Moslehi JJ, Shah SP, Ganatra S, Thavendiranathan P10, Lawrence DP, Groarke JD, Neilan TG.: Myocarditis in Patients Treated With Immune Checkpoint Inhibitors. J Am Coll Cardiol. 71 (16): 1755-1764,2018.

Faje AT, Lawrence D, Flaherty K, Freedman C, Fadden R, Rubin K, Cohen J, Sullivan RJ.: High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanoma. Cancer. 124 (18): 3706-3714,2018.

Academic Contact Info

Abramson Cancer Center
Pennsylvania Hospital
230 W Washington Square

Philadelphia, PA 19106
Patient appointments: 800-789-7366 (PENN)